Clin2
NCT07796490Possibly a fitNot yet recruiting

Botox injection before prostate removal for high-risk prostate cancer

Prostate Cancer

Treatments studied

Part of Cancer, Kidney & urinary clinical trials.

This trial tests whether injecting a nerve-blocking medication (Botox) into the prostate before surgery helps improve outcomes for men with high-risk prostate cancer. It's a way to possibly make the cancer easier to treat and reduce side effects during and after surgery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
30 people
Ages
45 years to 80 years
Study type
Interventional

Who can take part

  • You are a man aged 45 or older.
  • You have prostate cancer with a Gleason score of 8 or higher (this means the cancer looks more aggressive).
  • You are scheduled to have your prostate removed with robotic surgery (RALP) as your main treatment.
  • You have not had prior treatment for prostate cancer (like radiation, hormone therapy, or chemotherapy).
  • You are generally healthy enough to participate (can do daily activities).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07455903Recruiting· Phase 2
Hormone therapy before surgery for high-risk prostate cancer

This trial tests whether giving hormone therapy (androgen deprivation therapy) before surgery can improve outcomes for men with high-risk prostate cancer. You will receive a special PSMA PET/CT scan to see how the cancer responds.

Miami, Florida
NCT03753243Recruiting· Phase 2
Pembrolizumab and hormone blocker before prostate surgery

This Phase 2 trial studies whether pembrolizumab plus a hormone “androgen axis” blocker taken before prostate surgery can improve outcomes for people with high-risk, non-metastatic prostate cancer. It’s designed for patients who are planning prostate removal with an extended lymph node dissection.

Portland, Oregon
NCT06524219Not yet recruiting
Comparing nerve-sparing surgery for prostate cancer recovery

This trial compares two nerve-sparing surgery techniques for prostate cancer to see which one better protects urinary control and sexual function while still removing the cancer. It may help men with early-stage prostate cancer who are planning to have robotic surgery.

NCT06450106Recruiting· Phase 1
STM-416p injection during prostate removal surgery

This trial tests an injection called STM-416p given during prostate removal surgery to see if it can help prevent prostate cancer from coming back. It may be an option for men with intermediate to high-risk prostate cancer who are already planning to have their prostate removed.

Tucson, Arizona
NCT07747272Recruiting
Nerve-sparing prostate surgery and erectile function

This study looks at how your health before surgery affects your erectile function after robot-assisted prostate removal. It aims to help doctors predict and improve recovery of erectile function.

Florence, Italy
NCT04894188Recruiting
Hormone plus radiation before prostate surgery for high-risk cancer

This trial studies giving hormone treatment and radiation before prostate surgery to treat high-risk, locally advanced prostate cancer. It aims to improve cancer control by shrinking or controlling the tumor before removing it.

Douliu City/Huwei Township, Yunlin County

Hear when a new Prostate cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.